论文部分内容阅读
目的探讨阿托伐他汀在老年急性冠脉综合征治疗方面的临床疗效。方法我院72例老年急性冠脉综合征患者于2010年3月至2011年8月接受治疗,随机分成观察组与对照组。治疗前、后的30d与3个月时对病者心肌酶以及肝肾功能实施监测,两组在治疗前与治疗后30d通过速率散射比浊法对CRP含量进行测定;通过酶法对TC、LDL-C、HDL-C以及TG实施测定。结果观察组与对照组治疗30d分别出现1例与5例。在心脏时间对比中可以看到对照组的发生率较高于观察组,差异有统计学意义(P<0.05)。结论老年急性冠脉综合征治疗中采用阿托伐他汀,完全可以稳定动脉硬化斑块,同时对患者出现的验证反应有明显的抑制效果。
Objective To investigate the clinical efficacy of atorvastatin in the treatment of elderly patients with acute coronary syndrome. Methods A total of 72 elderly patients with acute coronary syndrome were treated in our hospital from March 2010 to August 2011 and were randomly divided into observation group and control group. The levels of myocardial enzymes and liver and renal function were monitored at 30 days and 3 months after treatment. CRP levels were measured by rate nephelometry before and 30 days after treatment. The levels of TC, LDL-C, HDL-C, and TG. Results In observation group and control group, there were 1 case and 5 cases respectively. In the comparison of cardiac time, we can see the incidence of the control group is higher than the observation group, the difference was statistically significant (P <0.05). Conclusions Atorvastatin is used in the treatment of elderly patients with acute coronary syndromes, which can stabilize atherosclerotic plaque completely and has obvious inhibitory effect on the patients’ verification reaction.